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ABSTRACT 
Diabetes mellitus is a disease that affects about 387 million people throughout the 
world.  It is characterized by the body’s inability to secrete or respond to insulin properly. 
As a result, diabetes mellitus is associated with hyperglycemia, the cause of many severe 
complications.  Calcification in blood vessel walls, one of the most adverse complications 
of diabetes, may trigger heart failure, hypertension, plaque rupture, stroke, and coronary 
ischemia.  In vitro and in vivo studies suggest that vascular calcification is a regulated 
process involving inhibitors and activators and resembling osteogenesis in bone.  High 
glucose levels have been shown to induce endothelial cell dysfunction, expression of 
calcification biomarkers in vascular smooth muscle cells, and activation of fibroblasts. 
The purpose of this study is to investigate the interactions between co-cultured vascular 
endothelial cells, smooth muscle cells, and fibroblasts under diabetic/hyperglycemic and 
normal conditions.  
Human coronary artery smooth muscle cells, human aortic adventitial fibroblasts, 
and human aortic endothelial cells were co-cultured in pairs with alternation of one cell 
type on the membrane of the Transwell insert and the other on the bottom of the well. 
The cells were cultured under high glucose levels or normal conditions for 2 weeks.  We 
performed immunofluorescence staining to examine the production of caspase-3 for 
apoptosis as well as osteocalcin and alkaline phosphatase as markers of calcification. 
Each surface was also stained with Alizarin Red Solution to observe the accumulation of 
calcium.  
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The immunofluorescent alkaline phosphatase and Alizarin Red S stains indicated 
that all of the co-cultures, regardless of diabetic or nondiabetic conditions, induced 
expression of alkaline phosphatase and calcium.  Osteocalcin was only seen on the cell 
surface of smooth muscle cells cultured on the membrane with fibroblasts in diabetic 
conditions and fibroblasts cultured on the membrane with smooth muscle cells in diabetic 
conditions.  
This study shows that intercellular communications between smooth muscle cells 
and fibroblasts could contribute to calcification of the vascular wall under diabetic 
conditions.  
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CHAPTER ONE 
INTRODUCTION & BACKGROUND 
1.1. Diabetes Mellitus 
Diabetes mellitus, commonly known as diabetes, is characterized by the body’s 
inability to secrete or respond to insulin properly. Insulin is a hormone that is important 
in the regulation of blood glucose levels. As a result of this defect, diabetes mellitus is 
associated with hyperglycemia (a pathologically elevated blood glucose level) which is 
attributed to the cause of many secondary complications and failure of various organs 
such as the kidneys, eyes, heart, nerves, and blood vessels [1]. Diabetes mellitus is 
considered equivalent to cardiovascular disease due to the high rate of complications 
experienced by the patients with this ailment [3]. About 387 million people throughout 
the world are affected by diabetes [2]. The development of diabetes mellitus is related to 
several pathogenic process such as insulin deficiency due to the autoimmune destruction 
of β-cells in the pancreas, which produce insulin within the islets of Langerhans, and 
abnormalities in the receptor tissues resulting in resistance to insulin. Defects in the 
insulin pathway action and impairment of the secretion of insulin are commonly both 
found in the same patient, so it is often hard to decipher the primary cause of 
hyperglycemia [1]. Although this common disease causes many complications and 
multiple studies have been conducted in order to characterize diabetes, further 
investigation is still needed due to the plethora of factors that play a role in the onset of 
diabetes. It is a result of many various factors such as genetics, autoimmune dysfunction, 
lifestyle, and environment [4].  Diabetes mellitus and its complications are not only a 
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burden to individuals suffering from the disease, but also the global economy as a whole, 
accounting for $245 billion in medical costs and lost work and wages within the United 
States in 2012 alone [5]. As much as 10 percent of many countries’ healthcare budgets is 
spent on treatment of diabetes [2].  
Most diabetic patients fall into two etiopathogenetic categories. Type 1 diabetes is 
caused by deficiency of insulin secretion. Type 2 diabetes is considerably more common, 
accounting for about 90-95% of the cases and is caused by a combination of insulin 
deficiency and insulin resistance of the body cells [1]. Type 1 diabetes is triggered by the 
autoimmune system attacking the β-cells within the pancreatic islets. β-cells secrete 
insulin in order to lower blood glucose levels. Insulin is a hormone that plays a major role 
in glucose homeostasis; it stimulates glucose uptake into fat and muscle and suppresses 
the output of glucose from the liver. Without the native islet cells to produce insulin in 
the body, patients must use outside sources to make up for the lack of this important 
hormone in their bodies.  Type 1 diabetes is treated through insulin injections to 
compensate for the lack of β-cells. This less prevalent form of diabetes is typically 
diagnosed in childhood or young adulthood and must be controlled through constant 
monitoring and treatment throughout the person’s life [2].  
The development of type 2 diabetes is contributed to multiple mechanisms. It is 
characterized by insufficient insulin secretion from the β-cells, as well as insulin 
resistance of target tissues. Hyperglycemia occurs when the secretion of insulin is not 
enough to compensate for insulin resistance. Obesity causes further insulin resistance, 
which is why risk in type 2 diabetic patients is enhanced by obesity and dietary control is 
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crucial in the treatment of type 2 diabetes [2]. Insufficient insulin secretion could be due 
to a decrease in the quantity of β-cells, the rate that the individual cells secrete insulin, or 
both. Recent evidence suggests that alterations in the β-cell identity may also contribute 
to defective insulin secretion through changes in the β-cell transcription factors [2]. 
Patients diagnosed with type 2 diabetes are reported to have a 2-fold to 4-fold higher risk 
of cardiovascular mortality rate compared to individuals without diabetes [3]. 
 
1.2. Vascular Calcification  
Calcification of vessels refers to hydroxyapatite deposits building up within 
cardiovascular tissues.  Researchers and scientists have recognized calcification for more 
than 200 years, but the pathogenesis still has yet to be understood [6].  Calcification may 
cause many negative clinical consequences, some of these including heart failure, 
hypertension, plaque rupture, stroke, and coronary ischemia [7].  The presence of 
calcified plaque in coronary arteries predicts an increase in mortality by 1.7-fold.  When 
this calcification is extensive, there is a 60-fold predicted increase in mortality. 
Calcification is observed in almost all patients diagnosed with cardiovascular disease [7].  
Type 2 diabetic patients are more likely to develop macrovascular calcification than 
nondiabetic patients.  This may be attributed to elevated pulse pressure in elastic arteries 
of the legs, stiffening of arterial tone, and an accelerated occlusive atherosclerosis process 
[6]. 
  In vitro and in vivo studies suggest that vascular calcification is a regulated 
process involving inhibitors and activators and resembling osteogenesis in bone [6]. 
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Calcium deposits within vasculature can be similar to bone from a macroscale level to 
nanoscale level [7].  Cellular components of deposits may include osteoclasts, 
osteoblasts, chondroclasts, chondroblasts, pericytes, osteocytes, vascular cells, and 
lymphocytes [7].  Analyzation of vascular lesion mineral content and cell cultures 
through energy dispersive x-rays consistently yields calcium phosphate molar ratios 
matching hydroxyapatite mineral [7].  Spectroscopy using nuclear magnetic resonance of 
calcified plaques reveals surface features matching bone on a molecular level [7].  In 
vitro, high glucose levels have been shown to induce expression of osteopontin and 
induce cell proliferation in vascular smooth muscle cells as well as transforming them 
into osteoblast-like cells [6]. 
  In addition to transdifferentiation of vascular cells, calcification can also cause 
stiffening of a vessel [6].  Calcium deposits in a vessel can create a compliance mismatch 
between the rigid plaques and more compliant artery well tissues and, consequently, 
affect plaque stability.  Under the mechanical stress an artery is subjected to, this can 
increase the risk of mechanical failure at the interface, resulting in plaque rupture. Plaque 
rupture is the thought to be the cause of most stroke and myocardial infarction events [7]. 
Calcium deposits cause a dramatic redistribution of stress in plaque-reducing the stress in 
some regions while increasing it in others [7]. 
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1.2.1.   Medial Calcification vs. Intimal Calcification 
 
  The two categories of vascular calcification according to location are medical 
calcification and intimal calcification. Intimal calcification appears as aggregates of 
calcium deposits on the tunica intima. The calcification then extends into the tunica 
media from the tunica intima [6]. It takes the form of atherosclerotic vascular disease and 
involves vascular smooth muscle cells and inflammatory macrophages in regions of the 
atherosclerotic plaque that are lipid-rich [8]. Intimal calcification is associated with 
ischemic heart disease due to embolism formation or obstruction of the vessel through 
calcified plaque build-up [8].  
  Medial calcification, also known as Mönkeberg’s arteriosclerosis, often 
affects the tunica media in patients with diabetes mellitus [9]. It is not associated with 
obstruction of the vessel lumen, as it does not involve the tunica intima, but it does 
decrease the compliance and elasticity [8]. This can lead to formation of atherosclerosis, 
reduction in perfusion [9], left ventricular hypertrophy, and systolic hypertension [8]. 
Medial artery calcification is a result of elevated levels of serum phosphate and calcium 
and is prognostic for diabetic complications, including mortality and amputation, in 
patients diagnosed with type 2 diabetes [9]. Both types of calcification often occur in the 
same patient, sometimes even the same arterial site [7]. Figure 1.1 is a diagram of the 
cross-sectional area of two vessels, depicting the difference in appearance between the 
two [10].  
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Figure 1.1: Diagram of Medial Artery Calcification vs Atherosclerotic Intimal Calcification 
 
1.2.2.   Mechanism of Calcification 
  Vascular calcification is a highly regulated process affected by both systemic 
and local factors. Some risk factors for calcification include high serum phosphate, 
calcium, or matrix metalloprotease levels, lipid modification, oxidative stress, and 
inflammation [17].  Smooth muscle cells seem to be the most studied cell type for the 
underlying mechanism of vascular calcification and will therefore be discussed most 
frequently in this section. Their ability to change from contractile cells to a proliferative, 
synthetic phenotype is critical in many vascular pathologies [18]. The contractile 
phenotype seems to be resistant to mineralization and/or apoptosis. Because they are 
mesenchymal cells, vascular smooth muscle cells can differentiate into other 
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mesenchymal-derived cell types when subjected to stress, such as chondrocytes, 
osteoblasts, or adipocytes. This transdifferentiation can lead to altered matrix production, 
calcification, and lipid accumulation [8].   
  MGP is a matrix protein that inhibits calcification and supports the elasticity 
properties of smooth muscle cells in normal physiological conditions [28].  It is also 
expressed during osteoblastic differentiation of vascular smooth muscle cells and 
vascular pericytes [17]. In mice models, it has been shown that the addition of MGP 
reduces calcification and atherosclerosis [27] and the absence of MPG causes extensive 
arterial calcification, eventually leading to death [26]. The molecular and cellular 
mechanisms by which MGP inhibits calcification include: inhibition of vascular smooth 
muscle cell transdifferentiation, regulation through the matrix vesicles and apoptotic 
bodies, and inhibition of calcium-phosphate precipitates [28]. MGP undergoes serine 
phosphorylation and glutamate carboxylation.  In order to function in inhibiting vascular 
calcification, MGP requires γ-carboxylation, which is driven through the presence of 
vitamin K [28].  When there is sufficient vitamin K, contractile vascular smooth muscle 
cells produce carboxylated MGP (cMGP), consequentially preventing mineralization 
[28]. If there are insufficient levels of vitamin K, and the MGP is uncarboxylated, elastic 
fibers can begin to calcify [30] and the vascular smooth muscle cell becomes detached in 
the blood vessel [31].   
 
  The first stress-induced change of vascular smooth muscle cells is to the 
synthetic phenotype, which can proliferate, migrate, and invade the tunica intima.  In 
 8 
vitro and animal studies show that the initiation of calcification is associated with an 
increased uptake of phosphate and calcium by smooth muscle cells [8].  Phosphate enters 
the cells through Na-dependent phosphate cotransporters in a concentration and time 
dependent manner. Calcium uptake is regulated by calcium-sensing receptors and 
voltage-gated calcium channels and is required for the contractility of vascular smooth 
muscle cells [8]. In vitro studies have shown that under high calcium conditions vascular 
smooth muscle cells undergo apoptosis and release more calcium in the process, which 
may result in more apoptosis. Apoptotic bodies form an origin site for calcification [8].  
Elevated levels of calcium can induce the mineralization of vascular smooth muscle cells, 
even in the absence of osteogenic differentiation [29].  High levels of calcium also lead to 
increased activity of matrix metalloproteinase-2 (MMP-2). 
  Matrix metalloproteinases are associated with the degradation of elastin, a 
process observed in most types of vascular calcification [20]. It has been observed in rat 
aortic smooth muscle cells that the presence of elastin-derived peptides causes an 
increased expression of MMP-2, osteocalcin, and alkaline phosphatase. Gene expression 
of osteocalcin and MMP-2 is substantially upregulated by elastin peptides, but does not 
seem to be affected by addition of TGF-β1 [20]. Alkaline phosphatase activity increases 
when the cells are cultured in media supplemented with TGF-β1 and elastin peptides 
more than when cultured with TGF-β1 or elastin peptides alone. This indicates that TGF-
β1 and elastin peptides promote calcification of smooth muscle cells in medial 
calcification in diabetes [20]. 
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  When vascular smooth muscle cells are in their synthetic form, they also 
produce matrix vesicles. If loaded with inactive uncarboxylated MGPs, matrix vesicles 
are also more likely to mineralize. Membrane-bound matrix vesicles serve as nucleation 
sites for hydroxyapatite, but do not calcify when loaded with the normally present 
mineralization inhibitors such as MGP and Fetuin-A [8]. Fetuin is a glycoprotein that is 
mainly produced by the liver. It appears to inhibit mineralization through both restricting 
hydroxyapatite crystal growth by constraining mineralization within collagen fibrils as 
well as by impairing the calcium-phosphate nucleation ability of the matrix vesicles.   If 
there is a high extracellular calcium level or intracellular calcium release when 
calcification inhibitor levels are not high enough, the smooth muscle cells produce 
vesicles that are contain preformed hydroxyapatite and alkaline phosphatase. The alkaline 
phosphatase inactivates pyrophosphate and osteopontin, inhibitors of hydroxyapatite 
crystal formation, and creates additional phosphate sources [8].  The hydroxyapatite 
microcrystalline structures and the glycosaminoglycan scaffolds in calcified vessels are 
the same as those found in bone tissue.  
  Medial calcification is associated with mineral imbalances due to a defect in 
metabolism.  At calcification sites, smooth muscle cells morph to an osteochondrocytic 
phenotype and upregulate the expression of mineralization-regulating proteins which are 
normally restricted to bone and cartilage tissues [8]. Phosphate is important mineral 
involved in the regulation of the osteochondrocytic transdifferentiation. This change 
involves downregulation of the smooth muscle cell genes and simultaneous upregulation 
of osteochondrocytic genes [8]. A key transcription factor for this process is Runx2. The 
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signaling of bone morphogenic proteins (BMP) is involved in the activation of Runx2 
transcriptional activity. Bostrom, et al. investigated the effects of diabetes on vascular 
BMP signaling activation and found, in vitro, that glucose increased BMP-2 and BMP-4 
expression [19]. High levels of fibroblast growth factor 23 (FGF-23) have been 
independently associated with increased cardiovascular disease [21]. Compelling 
experimental evidence has shown that when FGF-23 is neutralized with antibodies in in 
mice models, the result is calcification [Shimada 2004].  FGF-23 is a regulator of 
phosphate that is involved the bone tissue homeostasis and secreted by bone cells when it 
undergoes glycosylation [23]. When in becomes glycosylated it not only is released from 
the cell, but is also protected from being broken down. Due to its role in regulating 
phosphate, it could potentially enhance phosphate-induced calcification [24].  Once in 
their osteogenic phenotype, vascular smooth muscle cells begin to synthesis bone 
regulating proteins, such as osteocalcin, and less MGP [28].  This contributes to the bone-
like mineralization seen in calcified vessels. 
  Endothelial cells are also known to produce MGP, and due their high 
concentration in vessels, may be a significant source of MGP [28].  Multipotent vascular 
stem cells have also recently been identified, but their contribution to the production of 
MGP is not known [32].  Fibroblasts are less studied, but are known to contribute to 
calcification.  The osteogenic response of fibroblasts in medial vascular calcification is 
activated by elastin degradation products and TGF-β1 [25]. In vitro, rat dermal fibroblasts 
that were treated with TGF-β1 and elastin degradation products formed multicellular 
calcified nodule. These nodules also formed when the cells were treated with each 
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separately, but the effect was significantly amplified when used together.  Before 
mineralization, the fibroblasts expressed characteristic features of myofibroblasts: α—
smooth muscle actin, collagen type I, and MMP-2. α-SMA is a contractile protein seen in 
myofibroblasts (the activated, contractile phenotype of fibroblasts that are capable of 
differentiating into calcified vascular cells then osteoblasts). It has been shown that the 
migratory myofibroblasts originating from the adventitia respond to smooth muscle cell 
osteopontin production and contribute to medial calcification and vascular remodeling in 
diabetes [25]. Myofibroblasts are critical in normal tissue repair and typically undergo 
apoptosis when the integrity of the tissue has been restored. Their persistence at a site of 
injury may be connected to collagen accumulation and calcification [25]. 
  Figure 1.2 is a simplified schematic representing most of the vascular 
calcification mechanism described in this section [28]. Other hormones, cytokines, and 
cells may contribute to the calcification of vessels as well as those mentioned above, but 
the mechanism behind calcification is yet to be completely understood. 
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Figure 1.2: Mechanism of Calcification. Abbreviations: p- and dp-cMGP/ucMGP; 
phosphorylated and dephosphorylated forms of carboxylated and uncarboxylated matrix Gla 
proteins, respectively 
 
1.2.3.   Biomarkers of Vascular Calcification 
Two biomarkers that were analyzed in this study and are indicative of the presence 
of calcification in a vessel are osteocalcin and alkaline phosphatase. Osteocalcin, also 
known as bone Gla protein, is secreted by osteoblasts and is the most abundant 
noncollagenous protein present in bone matrix. It can undergo γ-carboxylation [11]. 
When osteocalcin is in its γ-carboxylated form, it binds hydroxyapatite [11]. This form of 
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the protein is also abundant in the extracellular matrix of bone and calcified vasculature. 
Osteocalcin expression is known to be found in calcifying vascular smooth muscle cells, 
but the physiological implications of this presence remains unclear [11].  
Vascular smooth muscle cells are thought to orchestrate the mineralization in vessels 
by osteochondrocytic differentiation within the vessel wall. This differentiation, as well 
as the glycolytic metabolism and glucose uptake of vascular smooth muscle cells, is 
stimulated by osteocalcin.  It has been demonstrated that osteocalcin mRNA is 
upregulated with the onset of vascular smooth muscle cell osteochondrocytic 
differentiation and osteocalcin accumulates in calcified vessel walls [12]. Osteocalcin has 
recently been recognized for its role in osteochondrogenic differentiation and as an active 
modulator of vascular smooth muscle cell signaling. Additional studies are needed to 
analyze the relationship between glucose metabolism and osteochondrogenic 
differentiation. Research to understand the important role of osteocalcin in metabolism 
regulation may help to decipher the relationship between metabolic disorders, such as 
diabetes mellitus, and vascular calcification. 
Alkaline phosphatase is an osteochondrogenic biomarker as well.  These enzymes 
are present in most organisms and function by catalyzing the hydrolysis of 
phosphomonomers, releasing alcohol and inorganic phosphate [13].  Three out of the four 
isozymes in humans are tissue specific and the fourth is tissue-nonspecific (TNALP). 
TNALP is found in bone tissue as well as human atherosclerotic lesions [13]. Its presence 
in the lesions suggests that it may play a role in promoting the accompanying 
calcification with the vessel. When TNALP expression is increased, calcification is 
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increased in bovine vascular smooth muscle cells [13]. Alkaline phosphatase is present in 
most cells as it is involved in cleaving phosphate groups, a common cellular process.  An 
increase in alkaline phosphatase levels indicates vascular calcification because alkaline 
phosphatase promotes calcification by reducing the levels of a medial vascular 
calcification inhibitor, pyrophosphate and effectively creating higher phosphate levels. 
Alkaline phosphate allows for hydroxyapatite crystal formation as well as the 
transdifferentiation of vascular smooth muscle cells. 
As previously described, apoptosis is also part of the mechanism of calcification in 
that cells that have undergone apoptosis can become mineralized and further the 
condition. The biomarker of apoptosis that we focused on is cysteinyl aspartic acid-
protease-3 (Caspase-3). When a cell fails to make proper connections or is nutrient 
deprived, it undergoes apoptosis. There are several molecular pathways for apoptosis, but 
the most common and studied ones are called the intrinsic and extrinsic pathways [33].  
Figure 1.3 depicts the extrinsic pathway to the left and intrinsic pathway on the right.  
The extrinsic pathway begins with ligand-induced death receptor activation.  There 
activation leads to the formation of the death-inducing signaling complex (DISC) within 
the cell on the plasma membrane.  This promotes initiator caspase-8, and possibly 
caspase-10 to cleave the effector caspase enzymes and proteolytically activate a link 
between the pathways called Bid. Bid promotes the mitochondrial membrane 
permeabilization seen in the intrinsic pathway [33]. 
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Figure 1.3. Pathways of apoptosis 
 
The intrinsic pathway of apoptosis begins with intracellular signals leading to 
activation within the mitochondria of the cell. Mitochondria develop a higher 
permeability in their membranes, allowing the release of cytochrome C. Cytochrome C is 
not normally a toxic protein, but can initiate apoptosis through the activation of caspase 
enzymes.  It first binds and activates Apaf-1 and procaspase-9 to form an apoptosome. 
Initiator caspase-9 is then activated, using proteolytic cleavage in order to activate the 
caspase effectors Caspase-3 and Caspase-7 [34].   
Caspase enzymes act catalytically, only needing a few initiator caspases in order to 
activate a large amount of effector caspases. Once activated, caspase enzymes have the 
ability to destroy the organelles and chromosomes within a cell.  The presence of 
cytochrome C activates one of the caspases, leading to the activation of the caspase 
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cascade which starts breaking down all of the cellular components.  Apoptosis happens 
within the cell membrane because the cell never bursts during the process. The membrane 
does, however, begin to express abnormalities that may lead to further reactions [34].  
Figure 1.4 is a diagram that simplifies the described mechanism behind the initiation of 
apoptosis.    
 
Figure 1.4. Initiation of intrinsic pathway of apoptosis  
 
1.3.          Vascular Cell Mechanics in Arteries 
   
 The cells within vasculature throughout the body -endothelial cells, smooth 
muscle cells, and fibroblasts- are constantly subject to stresses which activate 
mechanotransduction and result in modification of the vessel. Understanding how these 
cells interact with their environment within these vessels is imperative in the prevention, 
diagnosis, and treatment of vascular diseases. Endothelial cells are found on the inner 
wall of blood vessels, lining the lumen. Therefore they are constantly interacting with the 
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blood within the vessel. They communicate with the smooth muscle cells within the 
media and fibroblasts in the adventitia to regulate vessel function. Smooth muscle cells 
contract or relax in order to regulate blood flow.  Adventitial fibroblasts seem to 
primarily function as support for the vessel under normal physiological conditions. If the 
endothelial cells become damaged or undergo necrosis due to any pathology, the smooth 
muscle cells and fibroblast interact directly with the blood. That is why it is important to 
understand the impact of cellular interactions and hemodynamic forces on all three cells 
within blood vessels. 
 
1.3.1.     Endothelial Cells  
Endothelial cells are vital cells in vascular homeostasis. They function as a 
permeable barrier and carry out many functions such as: remodeling, proliferation, cell 
migration, apoptosis, regulation of contractility of smooth muscle cells in the vessel, as 
well as the metabolism, production, and secretion of biochemical substances [14]. In 
order to understand the general mechanics and regulation of circulatory function, it is 
important to first understand the significant roles of endothelial cells. The endothelial 
cells in vasculature are constantly subjected to mechanical stimuli such as fluid shear 
stress and stretch. They maintain their intracellular homeostasis using feedback controls 
that have been the subject of many genetic, molecular, and cellular studies [14]. In vivo 
studies of these mechanisms are advantageous in that the experimental variables can be 
controlled. In vivo studies are used to determine the applicability of the information 
learned from in vitro studies. 
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Endothelial cells line the lumen of vasculature and are constantly subjected to 
various fluid shear stresses based on the patterns of blood flow in the body. In vivo, 
arterial endothelial cells are characterized by their ellipsoidal shape with the long axes 
aligned with the direction of blood flow [15]. The biosynthetic activity, integrity, and 
regrowth of endothelial cells following injury are some of the processes that are affected 
by the stress applied by blood in vivo. Fluid shear stress is the force produced by a 
viscous fluid moving across a solid body which restricts its motion. An increase in the 
velocity of a fluid, as well as increased viscosity, cause the magnitude of fluid shear 
stress to increase [15]. Fluid velocity increases linearly with distance from the solid 
surface so near a plane boundary fluid shear stress can be calculated using the equation 
[15]: 
 
where τ is fluid shear stress (dynes/cm2), μ is the viscosity (gm/cm-s = Poise), and 
(dv/dz) is the velocity gradient (s-1). Normal fluid shear stresses of the major arteries 
during resting condition range between 2 dynes/cm2 and 20 dynes/cm2 [15]Near regions 
or sharp curvature and arterial branching localized increases can be seen to about 30-100 
dynes/cm2 [15]. In these branched or curved regions there is no well-defined direction to 
induce feedback mechanisms in order for the endothelial cells to maintain vascular 
homeostasis. The persistence of external stresses can lead to undesired signaling 
responses and eventual pathologies [14]. This change in shear stress has raised interest in 
the relationship between vessel obstruction and hemodynamics. With researchers 
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focusing on the fluid shear stress in vessels, we have been able to come to many 
conclusions such as: elevated shear force can damage endothelial cells, histamine 
synthesis increases with an increase in shear stress, and flow modifies the repair of 
endothelium [15].  
Dewey, et al. [15] developed a cone-plate apparatus to study the response of 
bovine aortic endothelial cells to various levels of shear stress.  For very small flow rates 
the specimens experience equal shear fluid shear stresses. For higher flow rates, the outer 
specimens experience higher shearing than those closer to the center. In this experiment 
they found that the growth kinetics or population of confluent endothelial monolayers 
were not significantly altered by 1 dyne/cm2 or 5 dynes/cm2 shear stress. Subconfluent 
cultures had a slight tendency of alignment at 5 dynes/cm2. Both confluent and 
Subconfluent cultures developed significant time-dependent morphological changes 
when exposed to 8 dynes/cm2 for 48 hours and seemed to keep this morphology beyond 
48 hours. This study showed that the shape and orientation of endothelial cells is 
sensitive to the magnitude of applied shear. Also, confluent cultures seemed to have less 
alignment, suggesting that secreted extracellular matrix or cell to cell contact may 
influence this behavior. In other experiments it has been shown that morphological 
changes in the cell have a direct correlation with reorganization of the endothelial cell 
cytoskeleton [15]. Sustained fluid shear stress with a consistent forward direction has 
been shown to remodel cytoskeletal fibers to be oriented in the shear flow direction. The 
stress fibers are also thickened, the peak cell height shortened, and the cell becomes 
stiffened. Cytoskeletal remodeling is not observed when the flow is disturbed [14]. His 
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experiments also emphasized the influence that shear stress can have on the proliferation 
and morphology of endothelial cells [15].  
 In experiments conducted by Chein [14], flow chambers were used to analyze the 
effect of shear stress on endothelial cells. They used various cultured vascular endothelial 
cells including: bovine aortic endothelial cells (BAECs), human umbilical vein 
endothelial cells (HUVECs), and human aortic endothelial cells (HAECs). The channel 
was used to create a steady fluid shear rate of 12 dynes/cm2, pulsatile shear at 12 ± 4 
dynes/cm2, and reciprocating shear stress at 0.5 ± 4 dynes/cm2. Applying shear stress can 
activate a multitude of mechanosensors. Some of these include membrane proteins like 
receptor tyrosine kinase, integrins like αvβ3, α2β1, α5β1, and α6β1, G proteins and G protein-
coupled receptors, calcium channels, and intercellular junction proteins. Krüppel-like 
factor-2 (KLF-2) is expressed in endothelial cells and is beneficial to its survival. Using 
the pulsatile shear stress with a significant forward direction compared to the 
reciprocating shear stress on HUVECs it was found that both types of shear stress 
increased mRNA levels of KLF2 after 1 hour. After four hours there was a drop in the 
KLF2 gene expression of endothelial cells with reciprocating shearing. This level 
remained low for as long as 24 hours. The pulsatile shear stress sustained upregulation 
throughout the testing period. According to this experiment, reciprocating shear stress 
applied for 24 hours inhibits expression of KLF2 and reduces the ability of endothelial 
cells to survive when subjected to oxidative stress. In contrast, the pulsatile shear stress in 
the forward direction is beneficial to endothelial cell survival by allowing continued 
expression of KLF2. Further experimentation of HAECs at a steady shear stress of 12 
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dynes/cm2 for 24 hours suggests that sustained shearing in a forward direction keeps 
endothelial cells from hyperplasia or activating the inflammatory response through the 
downregulation of genes related to these functions. Genes involved in angiogenesis and 
endothelial cell survival were significantly upregulated by this shear stress [14]. 
 In vivo studies of several animal species have supported the findings of these in 
vitro studies. In the straight part of vasculature, stress fibers within endothelial cells are 
oriented parallel to the shear stress applied by blood flow. There is little orientation of 
endothelial cells at branch sites that are lateral to the vessel dividers, where the blood 
flow direction is more disturbed. Partial obstruction in the aorta or common carotid 
arteries has been shown to cause a decrease in shear stress downstream of the obstruction 
and, consequently, a reduction in endothelial cell elongation and oriented stress fibers. 
The reasoning behind this orienting mechanism is that it minimizes the intracellular stress 
and strain when there is a continued presence of applied fluid shear stress [14].  Figure 
1.3 is a schematic diagram showing the forces acting on the endothelial cells as blood 
flows through vasculature [14].  
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Figure 1.5: Forces acting on endothelial cells within a blood vessel 
 
 The other main stress applied to endothelial cells is the cyclic stretch caused by 
pulsating blood pressure in blood vessels. Chien [14] studied the effects of uniaxial and 
biaxial stretching on BAECs seeded onto silicone membranes. Both modes of stretch 
caused and increase in actin stress fibers, but had different effects of the orientation of the 
fibers. Biaxial stretch does not seem to cause the stress fibers to remodel into any specific 
orientation whereas the uniaxial stress caused alignment perpendicular to that of the 
stretch. If the sample was stretched less than 3%, there was no significant orientation of 
the fibers. As the extent of the stretching increases, so does the amount of fiber 
orientation. At 10% uniaxial stretch, the cells showed an almost completely perpendicular 
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orientation [14]. This is also seen in vivo where arteries are parallel to blood flow and 
perpendicular to the stretching force applied from the blood. 
 The current understanding of the role endothelial cells play in vasculature has 
come a long way, but there is still room for improvement. It is known that fluid shear 
stress or stretch causes changes in intracellular mechanics as well as 
mechanotransduction. All of these pathways and their interactions still are not completely 
understood. It is also known that a clear direction of mechanical stimuli, such as uniaxial 
stretch or pulsatile flow, can cause endothelial cell remodeling that may serve to 
minimize changes in intracellular stress. This remodeling through mechanotransduction 
can also modulate molecular signaling. Some important questions that remain about fluid 
shear stress is how the long-term changes in flow rate can cause pathological changes in 
blood vessel endothelial cells, which interactions play central parts in these pathologies, 
how combinations of the mentioned stresses might affect endothelial cells, and how to 
reverse vessel injury and keep endothelial cells in their correct orientation. Further 
studies with bioreactors and tissue engineered constructs are beneficial in better 
understanding the mechanisms and propose solutions. 
 
1.3.2.      Smooth Muscle Cells and Fibroblasts 
 Although endothelial cells directly sense the alterations in blood flow and are the 
most commonly studied vascular cell in fluid mechanics, smooth muscle cells and 
fibroblasts still play a role in regulating vessel function. Endothelial cells detect the 
mechanical stimuli then send signals to the cells in the media and adventitia to elicit 
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feedback mechanisms. When the endothelial layer of a vessel is damaged, shear stress 
may have a direct impact on the medial smooth muscle cells and interstitial flow may be 
intensified on vascular smooth muscle cells and fibroblasts. There have been more 
studies recently that have investigated and found that interstitial flow and shear stress 
significantly influence smooth muscle cells and fibroblasts [16]. 
 The main functions of smooth muscle cells in the middle layer of the arterial wall, 
the media, are to regulate and maintain blood pressure, blood vessel tone, and blood flow 
distribution [16]. Smooth muscle cells have a high plasticity which allows them to make 
reversible changes in their phenotype between a synthetic state and contractile state in 
response to external stimuli that is vital for vascular repair and remodeling. Vascular 
smooth muscle cells may also contribute to lesion formation by migrating into the inner 
layer of the vessel wall when exposed to an abnormal environment, such as vascular 
injury [16]. This mechanism is important to study because common procedures such as 
angioplasty can injure the intima and cause further pathologies. Following injury, 
contractile smooth muscle cells change phenotype to their synthetic state and migrate into 
the intimal layer. Adventitial fibroblasts activate to become myofibroblasts and migrate 
across the media into the intima. The myofibroblasts and smooth muscle cells then 
proliferate and secret extracellular matrix components, eventually forming a neointima 
[16]. 
 Medial smooth muscle cells are also exposed to shear stress through interstitial 
flow by a pressure difference between the arterial pressure and tissue pressure. The 
magnitude of this fluid shear stress is usually very minuscule so it is a much more subtle 
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mechanism. Tarbell’s group [16] theorized an estimate for the shear stress from 
interstitial flow (τ) to be  
τ  
where Kp is the tissue’s Darcy permeability, is μ is the fluid viscosity, and U is the 
velocity of the superficial flow. This equation does not give an exact value and does not 
take into account that smooth muscle cells may experience higher shear stresses when 
near the pores due to funneling into the pores [16]. During wound healing of formation of 
a vascular lesion, interstitial flow on smooth muscle cells and fibroblasts decreases.  
 The majority of studies on the effects direct shear stress has on smooth muscle 
cells have been in vitro, due to their position within the vessel wall making direct shear 
stress difficult to create in vivo. From these studies, mostly done in 2D, it is seen that 
fluid shear stress can regulate vasoactive mediators, cytokines, and other signaling 
molecules. This is indicative of the important role that smooth muscle cells may play in 
vascular homeostasis. There are dramatic differences of cytokine release rates between 
smooth muscle cell cultures in 2D and 3D [16]. Because of this fact, we must come up 
with more realistic 3D models to properly characterize the behavior of vascular smooth 
muscle cells and fibroblasts. Permeability is also an important factor to focus on when 
making in vitro models. It is strongly dependent on the matrix material concentration. For 
example, the Darcy permeability in 2.5-45 mg/mL collagen gels is about 10-8 – 10-12 cm2, 
which is more than two orders higher than the Darcy permeability of a rabbit aortic wall 
[16]. This permeability is a significant factor, as seen in the theoretical equation, and 
must be considered in future models. A better understanding of the mechanotransduction 
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pathways between vascular cells and the extracellular matrix is needed to create better 
models for understanding blood vessels and creating tissue engineered solutions. Looking 
into the combinations of hemodynamic forces and their effects on smooth muscle cells 
and fibroblasts may provide better comprehension of what we must do to treat vascular 
diseases. The vascular endothelial cells’ interactions with hydrodynamic forces is 
important to explore, but we must not downplay the importance of the other vascular 
cells in the process. 
 
1.4.          Current Treatment Options 
There is currently no cure for diabetes or vessel calcification. The most 
commonly accepted treatments for diabetes focus on managing blood glucose levels.  
Patients with type 1 diabetes manage their symptoms using a blood glucose level monitor 
with insulin injections, diet to monitor sugar levels, and exercise.  The management of 
the disease for type 2 diabetic patients includes losing weight, regular exercise, and a 
monitored diet [35]. Most drugs that have been created in attempt to cure diabetic 
patients of medial calcification do not help, and some have extreme side effects.  
 Diabetes induced calcification can eventually lead to a need for surgical 
procedures in order to replace the affected vessels. Autologous grafts, often the 
saphenous vein, are typically the method of surgical intervention, but they may not be 
available due to previous uses or morbidity [36].  Other bypass grafts that have been 
proposed include xenogeneic grafts and synthetic grafts, but they have limitations such as 
thrombosis [36]. Patients with diabetes may also develop critical limb ischemia leading to 
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an increased risk of limb loss and mortality after revascularization surgery [38].  Diabetic 
patients also have difficulties with percutaneous coronary interventions such as 
angioplasty, often resulting in occlusion from restenosis [37].   A higher incidence of 
restenosis is also observed when diabetic patients have drug-eluding or bare-metal stents 
implanted [39].   
 Because the mechanism behind calcification in diabetic patients is not known, the 
complex interactions with this condition and surgical procedures and biomaterials also 
remains unknown.  Further research to understanding this mechanism can lead to better 
solutions in improving the quality of life for diabetic patients dealing with this ailments. 
 
1.5.          Blood Vessel Tissue Engineering 
 Tissue engineering is a promising solution for the treatment of blood vessel 
pathologies. The goal of tissue engineering is to replace any diseased tissue in the body 
with an engineered tissue that can restore function and will regenerate over time. By 
combining knowledge from engineering, biology, and material science, it has to potential 
to create and repair blood vessels [40]. The currently used synthetic or native grafts are 
only effective for large-diameter grafts, due to having a thrombogenic effect in small 
diameter grafts [40].  With the availability of autologous material being limited due to 
commonly systemic nature of diabetes, affecting sites throughout the vasculature, there is 
considerable effort being focused on creating biocompatible prosthetic grafts [40]. 
 The general paradigm of tissue engineering usually begins with cells being 
cultured in vitro then seeded on a scaffold made of biological material or synthetic 
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polymer [41]. The populated scaffold is then conditioned with mechanical and chemical 
stimuli in a bioreactor until there is a sufficient amount of extracellular matrix.  The 
conditioned construct is implanted into the appropriate area in the body, where it will 
remodel in vivo to further mimic the normal functioning tissue or organ [41].  Because 
this approach has regenerative properties and the cells integrated are specific to the 
patient, there is no need for immunosuppressive drugs as in most cardiovascular implants 
[42]. One of the main challenges is to make the vessels that will be resistant to also 
acquire the disease from the calcification cytokines present in the diabetic patient.  In 
order to get to that step, we first need to make a tissue-engineered vessel that will become 
completely integrated and functional in the human body.  It must be able to withstand the 
chemical and mechanical stresses applied to blood vessels every day. Insuring the 
preservation of the function of tissue-engineered blood vessels is vital in creating a 
sustainable construct. 
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Figure 1.6: Tissue-engineered blood vessel scaffolds in a bioreactor. Image and bioreactor from 
George Fercana at Clemson University. 
 
1.5.1.       Scaffold-Based Approaches 
 Bioengineers have been developing and analyzing various materials as possible 
vascular scaffolds for years to find the ideal properties for implantation.  The two 
categories of scaffolds discussed in this section are synthetic scaffolds and biological 
scaffolds. Scaffolds are advantageous in tissue engineering in that they provide a 
structure for cells to proliferate on, in contrast to injecting the cells and hoping they form 
enough matrix material to stay stationary and resist the mechanical forces in the body.  
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Within vasculature, the extracellular matrix is the natural scaffold with proteins to 
support the stabilization and organization of cells into the functional blood vessels [43].  
Replacing this scaffold while the cells are integrating may be a critical part in the 
formation of a tissue-engineered vessel. 
 Synthetic polymers are unique in their ability to be modified and controlled 
consistently during their fabrication. Rate of degradation, strength, and structure are 
much more easily modified than in biological scaffolds. The control of their properties is 
advantageous when studying the effect of the properties on cells as well as making 
vessels with consistent properties.  The effect of scaffold structures and rigidity on cell 
behavior is one example of their applicability for research purposes [43].  Some examples 
of synthetic materials that are used for the synthesis of vascular grafts are polyethylene 
terephthalate, polyurethane, expanded polytetrafluoroethylene, polyglycolytic acid, and 
poly(lactic acid). Ideally, these polymers would provide the initial mechanical strength 
and would resist any adverse reactions in the body [44].  Synthetic polymers have shown 
efficacy for large diameter vascular bypasses, but are not suitable for the replacement of 
small-diameter vascular tissues.   
Although some synthetic scaffolds seem to be viable options for vascular 
bypasses, all synthetic materials in the body will eventually undergo some type of 
biocompatibility response [42]. This is where biological scaffolds show unique potential 
for tissue engineering. Biological scaffolds can be derived from xenogeneic or allogeneic 
tissues while removing any cells that may cause an immune response.  After being 
decellularized, many scaffolds have shown to retain their mechanical properties, 
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extracellular matrix integrity, and cell signaling molecules. They can also be comprised 
of pure extracellular matrix components. Collagen, fibrin, and elastin are commonly used 
biological proteins for creation of vascular scaffolds [44].   
 
1.5.2.       Scaffold-Free Approaches 
 Scaffold-free approaches have emerged due to the problems that have arisen when 
creating tissue-engineered constructs using scaffolds [45]. A few weaknesses of scaffold 
approaches are: scaffolds have been linked in reduced cellular communications, the low 
strength of gels used may cause the final tissue-engineered vessel to be weak as well, and 
residual polymer fragments might disrupt organization of the vessel wall or change the 
smooth muscle cell phenotype [45]. Many different techniques have been utilized to 
develop a tissue replacement without any scaffold, made only of the native cells and their 
matrix components. Despite efforts, scaffold-free tissue-engineering has not had any 
clinically applicable solutions yet due to the lack of a reliable mechanism to create 
precisely formed tissues [45]. 
Sheet-based tissue engineering has been one proposed solution to this challenge.  It uses 
an automated, three-dimensional, computer-aided prototyping machine that deposits 
multicellular spheroids into a defined topology from a bioprinter with the aid a substance 
such as agarose rods to make a tubular shape. This method also allows for control of the 
vessel diameter, thickness, and branching pattern. Although this scaffold free approach 
does seem promising, it does have some major challenges to match the mechanical, 
biological, and chemical properties to that of the natural vessel [46]. There is yet to be an 
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established, plausible solution, but many advancements have been made toward the 
creation of artificial blood vessels with or without the presence of a scaffold. 
 
1.5.3.       Requirements for Successful Tissue Engineering 
 Tissue engineering holds great potential for the treatment of blood vessel 
pathologies, such as calcification.  One major consideration that must be made in the 
development of these solutions is that they should be resistant to the reoccurrence of the 
disease complications.  The chemistry and mechanical environment present in the body 
of a diabetic patient results in the calcification of vessels, so replacing the diseased vessel 
with a functional vessel with the same chemistry would likely produce the same outcome.  
We must learn more about the mechanism of calcification and develop a way to 
counteract the effects of hyperglycemia on blood vessels.  Other important considerations 
when designing a tissue engineered blood vessel must include biocompatibility of the 
construct, its ability to regenerate in vivo, its resistance to degradation, integration into 
the vascular system, and restoration of physiological function, including the passage of 
gases and nutrients.  Significant progress has been made in this field, but much more 
research is needed before tissue-engineering results in a long-term viable solution. 
 
1.6.         Rational for Model 
 The purpose of this research was to better understand the cellular interactions that 
mediate vascular calcification in diabetic patients.  Our approach was to use Transwell 
inserts within 6-well plates to co-culture each combination of the primary vascular cell 
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types in diabetic and diabetic media. Calcification in diabetes is known to be, in part, 
contributed to the high glucose levels causing cellular changes. This model allowed for 
the cells to interact with cytokines and growth factors from the other cell types in high 
glucose conditions without have extracellular matrix components to contribute to any 
changes.  Although the extracellular matrix components have been shown to play a 
significant role in calcification, this simplified model allowed for analyzation of the 
cellular interactions under high glucose conditions without the influence of these 
components. It is relevant to understand how these cells interact when co-cultured, 
because they trigger the calcification of the blood vessels through transdifferentiation into 
osteoblasts. The short 2 week culture was also to analyze the differences between just the 
cells, not other blood vessel constituents. If given more time, the cells start to secrete 
extracellular matrix components, which as mentioned, would contribute to calcification.  
In summary, this model was created in order to analyze any early modifications that the 
interactions of each cell type under high glucose conditions may induce in calcification of 
blood vessels in diabetic patients. 
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CHAPTER TWO 
 
MATERIALS & METHODS 
 
2.1.    Cell Culture 
 The cells used for this experiment were human coronary artery smooth muscle 
cells (HCASMC) (isolated by Lonza), human aortic endothelial cells (HAEC) (isolated 
by Lonza), and human aortic adventitial fibroblasts (HAoAFB) (isolated by Lonza). All 
of the specialized cell media were from Lonza: the SmGM-2 Bullet Kit (#CC-3182) for 
HCASMCs, the EGM-2 Bullet Kit (#CC-3162) for HAECs, and the SCGM Bullet Kit 
(#CC-3205) for HAoAFBs. Each cell type was cultured separately for 1 week in their 
respective specialized medium. After there was enough of each cell type to cover 3,500 
cells per square centimeter of the culturing surfaces, they were switched to the 6-well 
plates with Dulbecco’s Modification of Eagle Medium (DMEM, Corning-Cellgro).  
The  media that represented diabetic conditions was 1X DMEM with 10% fetal 
bovine serum (FBS), 1% antibiotic solution (Corning – Cellgro) , and 5.5 g/L glucose 
(added 4.5 g/L D-(+)-Glucose Monohydrate (#1.08342.1000, EMD Chemicals)). The 
control media did not have additional glucose added, only the 1 g/L of glucose that comes 
in the 1X DMEM. Each combination of cell groups was co-cultured in pairs with 
alternation of one cell type on the membrane of the 6-well Inserts with 0.4 μm pores 
(#29442-104, VWR Scientific) and the other cell type on the bottom of the sterile 6-well 
plate included with these inserts. A total of 24 diabetic well and insert groups were co-
cultured and 24 non diabetic well and insert groups. All of the cells were co-cultured in 
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the well and membrane systems for 2 weeks with removing half the media and adding 
fresh media every 3 days. 
 
2.2.    Immunofluorescence 
 After the cells were co-cultured for 2 weeks, the cells were stained to observe the 
presence of caspase-3, osteocalcin, and alkaline phosphatase. To do this, four more 6-
well plates were labeled according to the membrane groups 1-24 to store the membranes 
for staining. Using sterile forceps, the Transwell inserts were transferred to the new 
plates. Each polycarbonate membrane was cut out from the insert onto the bottom of the 
well using a sterile scalpel by pressing the blade against the edge and slowly turning the 
insert in the well to cut out the circular bottom. Next, the media was taken from each well 
and stored for MMP analysis. All of the wells were rinsed with 2 mL of 1X PBS then 
fixed with p-formaldehyde for 30 minutes. They were then rinsed with 1X PBS three 
times and then permeabilized with 0.2% Triton for 5 minutes at room temperature. The 
wells were rinsed again three times with 1X PBS and blocked with blocking solutions 
(5% bovine serum albumin, 0.05% Triton, 94.95% 1X PBS) for 2 hours at 4˚C. The 
blocking solution was removed and the primary antibodies: mouse monoclonal [OCG3] 
to osteocalcin (#ab13420, Abcam), mouse monoclonal to caspase-3 (#MA1-16843, 
ThermoFisher Scientific), and rabbit polyclonal to alkaline phosphatase (#ab65834, 
Abcam), were diluted according to the manufacturers’ specifications in blocking solution 
before being added to the wells at 4˚C overnight.  
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The primary antibodies were then recovered and the wells were rinsed three times 
with 1X PBS. The lights were turned off and the secondary antibodies were diluted 5 
μg/mL in blocking solution to add 0.7 mL of each solution per well. Donkey anti-mouse 
IgG Alexa Fluor 594 (#A-21203, ThermoFisher Scientific) was added to the wells with 
the caspase-3 primary antibody. Donkey anti-mouse IgG Alexa Fluor 488 (#A-21202, 
ThermoFisher Scientific) and donkey anti-rabbit IgG H&L Alexa Fluor 594 (#ab150076, 
Abcam) were added to the wells that were being stained for both osteocalcin and alkaline 
phosphatase presence.  The secondary antibodies were left on the cells in the dark for one 
hour while the well plate was on a shaker. After the incubation period, the secondary 
antibodies were removed and the wells were washed three times with 1X PBS. Enough 
DAPI solution (#D9542, Sigma) was added to cover the bottom of each well for 2 
minutes before the cells were rinsed a final time with 1X PBS and stored in PBS with the 
plates wrapped in Parafilm M and aluminum foil until they were imaged via fluorescence 
microscopy. 
 
2.3.    Alizarin Red Staining 
Alizarin Red Solution was obtained and adjusted to a pH of 4.1. The 1X PBS that 
the cells were stored in was removed from each well. The wells were then rinsed twice 
with ddH2O. The ddH2O was completely removed and 2 mL of Alizarin Red Solution 
was added to each well. The plates were placed on a rotator and incubated at room 
temperature for 20 minutes. After the dye was removed, the wells were washed 5 times 
with ddH2O. Then, the ddH2O was removed and 1:1 dilution of hematoxylin and ddH2O 
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was added for one minute. Each surface was then rinsed five more times with ddH2O and 
stored in ddH2O with the plate covered with Parafilm M until each group could be 
imaged using light microscopy. 
 
2.4.    Protein Extraction 
In order to extract proteins from the samples, a RIPA Buffer extraction procedure 
was used. First, four separate 6-well plates had to be labeled in order to keep up with the 
Transwell membranes. Using sterile forceps, the Transwell inserts were transferred to the 
new plates. Each polycarbonate membrane was cut out from the insert onto the bottom of 
the well using a sterile scalpel by pressing the blade against the edge and slowly turning 
the insert in the well to cut out the circular bottom. The RIPA buffer that was made 
consisted of 50 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 1% 
Sodium Deoxycholate, and 0.1% SDS. The buffer was adjusted to a pH of 7.4 and 10uL 
of Sigma P-8340 protease inhibitor cocktail per mL of RIPA Buffer was added right 
before use. The media was taken out from each well and stored for MMP analysis. Then, 
2 mL of 1X PBS was added to each well. The PBS was aspirated off and 500 μL of RIPA 
Buffer was added to each well. Using a different rubber policeman for each group, the 
cells were thoroughly disturbed by scraping each membrane and well bottom in every 
direction all over the surface. Then the solution for each group was placed into a labeled 
2 mL conical tube, mixed with a vortex, then put in a 4˚C refrigerator for one hour. 
Following the incubation period, the samples were spun down using a centrifuge at 
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12,000 x g for 15 minutes. The supernatant was removed from the samples and stored in 
a 1.5 mL conical tube with a closed cap at 80˚C until the samples were analyzed. 
 
2.5.   Total Protein Assay  
A microplate bicinchoninic acid (BCA) assay was used to quantify the 
concentration of proteins in each sample. To do this, a Pierce Biotech (Rockford, IL) kit 
was used. Six diluted albumin standards were prepared at concentrations ranging from 0-
2000 μg/mL and then inserted into a 96 well plate in order to create a standard curve.  
After the standards, 25 μL of each sample was also inserted into the 96 well plate. The 
BCA Working Reagent (WR) was mixed with 34.3 mL of Reagent A and .7 mL of 
Reagent B in order to add 200 μL of WR per well. The plate was then mixed on a shaker 
for 30 seconds and moved to incubate at 37˚C for 30 minutes. After the plates were 
cooled to room temperature the absorbance was measured at 562 nm.  
This procedure was repeated for the protein analysis, because the concentrations 
were too low. Before repeating the BCA assay, the proteins were concentrated by a factor 
of 12x through to use of Amicron Ultra-0.5 Centrifugal Filter Unit with Ultracel-10 
membrane (#UFC501096, Millipore). The filter devices were inserted into a 
microcentrifuge tubes and up to 500 μL of a sample was added into each filter device. 
Next, the filter device was capped and centrifuged for 10 minutes at 14,000 x g with the 
cap straps aligned towards the center of the rotor. The assembled devices were removed 
from the centrifuged and separated from the microcentrifuge tube. To recover the newly 
concentrated solute, the filter device was placed upside down in a clean microcentrifuge 
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tube with a cap and centrifuged for 2 minutes at 1,000 x g. The ultrafiltrate was stored 
into the centrifuge tube until the BCA Assay was performed. 
 
2.6.    Western Blot 
To prepare the samples, the volume of sample solution need for a concentration of 
20 μg of protein per well was calculated from the BCA assay. The concentration of non-
reducing sample buffer and volume to bring all samples to the same volume was 
calculated as well. There was about 42 μL of each sample and buffer solution total, so 2.1 
μL of beta-mecraptoethanol (BME) was added to each sample mixture. The 2 mL conical 
tubes were then locked shut and placed in a stand to boil for 5 minutes. During this time, 
the electrophoresis chamber was assembled. The Mini-PROTEAN TGX Gels (#456-
1084, Bio-Rad) were placed into the chamber after the comb was removed from the top 
and sticker from the bottom. The electrophoresis module was filled with 1X 
electrophoresis buffer (diluted with ddH2O from 10X buffer: 25 mM Tris, 192 mM 
glycine, 0.1% SDS).  
After the samples had finished boiling for 5 minutes, 45 μL of each sample was 
added in the lanes as well as 45 μL of 1X sample buffer and 10 μL of the molecular 
weight standard (#161-0375 Precision Plus Protein Standards, Kaleidoscope, Bio-Rad).  
The gel electrophoresis was ran for 35 minutes at 200 V with the module surrounded by 
an ice bath. While the electrophoresis was running, the polyvinylidine fluoride (PVDF) 
membrane was prepared for each gel.  To do this, a sizing jig was used to cut out the 
correct size from a large roll of PVDF. The membrane was never touched, only the outer 
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blue sheets covering the membrane. The PVDF membrane was removed from the outer 
sheets with a pair of plastic tweezers from the corner of the membrane. A small cut was 
made on the bottom left corner of the membrane to keep up with the orientation. Then the 
membrane was placed in 100% methanol for 20 seconds, ddH2O for 2 minutes, and 
transfer buffer (to process 2 gels made 4L of ddH2O with 6.06g Tris, 28.8g Glycine, 
200mL methanol) for at least 5 minutes. The membrane was lightly pressed into the 
liquid to keep it submerged if needed during these soaks.  
When the gels were done with the electrophoresis cycle, they were removed from 
the module. Each gel was carefully removed from the glass plates covering the gel. The 
borders of the gels were cut away before the gels were placed in individual containers 
containing transfer buffer and allowed to cool to room temperature for 15 minutes. 
During the equilibration time, the electrode holder box was washed in order to remove 
SDS before it could be used with the transfer cell and Tris buffer (50 mM Tris (12.1g), 
150 mM NaCl (17.52g), 2L of ddH2O, pH 7.5) was made if it had not been made ahead 
of time. After the gels were cooled, the gel sandwiches could be made for transferring the 
protein to the PVDF membrane. This sandwich consists of 1 cassette, 1 PVDF 
membrane, 2 filter papers, and 2 fiber pads per gel. All of the components were pre-
soaked with transfer buffer in a Pyrex pan. The gel sandwich was stacked from the black 
side of the cassette up, in the following order: pre-wetted fiber pad, pre-wetted filter 
paper, gel, PVDF membrane, pre-wetted filter paper, pre-wetted fiber pad, then the clear 
side of the cassette was on top. Once the stacking was complete, a serological pipette was 
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rolled over the top fiber pad in order to remove any air bubbles before the cassette was 
closed tightly.  
The gel sandwich pas placed into the transfer cell with the black side of the 
cassette facing the black side of the transfer cell.  Then the transfer cell was placed into 
the clean electrophoresis module filled with transfer buffer and containing an icepack and 
small stir bar in the center. Next, the module was placed in a bucket full of tightly packed 
ice, half filled with water. With the stir bar spinning and the module hooked up to the 
power source, the electrophoresis module ran for 60 minutes at 100 volts. During this 
time, the 2% non-fat dried milk (NFDM) solution (2% NFDM in 200 mL Tris Buffer) 
was made. When the run was complete, all solutions were allowed to equilibrate to room 
temperature.  Before blocking, the membranes were carefully removed from their gel 
sandwiches. The side that was facing the gel was marked with L1 or L2 in pencil and 
kept facing upward for the remainder of the steps.  
To block the blots they were each placed in their own container with 50mL of 2% 
NFDM for one hour on a shaker.  Next, they were incubated overnight at 4˚C while 
shaking in 25 mL each of primary antibody solution (1 μg/mL of donkey anti-mouse IgG 
Alexa Fluor 488 (#A-21202, ThermoFisher Scientific), 1 μg/mL of donkey anti-rabbit 
IgG H&L Alexa Fluor 594 (#ab150076, Abcam), 50mL of 2% NFDM solution). 
Following the incubation period, the primary antibody solutions were removed and 
frozen to reuse for the next western blot.  The membranes were then washed three times 
for 15 minutes each wash in 100 mL of Tris-Tween solution (1 mL of Tween20 (EM 
Science) in 1 L of Tris buffer).  They were placed in different containers and washed two 
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times for 12 minutes in 50 mL of 0.5% NFDM diluted in Tris solution on a shaker. The 
next step was to incubate the membrane for 90 minutes with shaking in 30 mL/blot of a 
secondary antibody solution (3.6 μL in 60 mL 1% NFDM, secondary antibody from BM 
Chemiluminescence Western Blotting Kit (Mouse/Rabbit), Roche Diagnostics). Then the 
membranes were washed four more times for 15 minutes in 100 mL of Tris-Tween 
solution. They were transferred to a new container in Tris buffer and moved to be 
imaged. A detection solution was prepared and stored in the dark consisting of 250 μL of 
starting solution B of the BM Chemiluminescence Western Blotting Kit and 25 mL of 
substrate solution A from the kit. The Bio-Rad imager was used to capture an image of 
each blot. 
 
2.7.    MMP Detection 
First, a microplate BCA assay was used to quantify the protein concentration in 
each media sample. Gelatin zymography was then performed in order to quantify the 
amount of MMPs in each media sample. Premade 10% Ready Gelatin Zymogram Gels 
(#1611167, Bio-Rad) were used for this procedure. First, the collected media was thawed 
in a 37˚C water bath for 30 minutes. Next, samples were mixed 1:2 with the 1x non-
reducing sample buffer (3.55 mL distilled water, 1.25 mL of 0.5 M Tris-HCl, 2.5 mL 
glycerol, 2 mL of 10% SDS, 0.2 mL of 0.5% Bromophenol Blue) according to the 
volume that was calculated from the BCA assay. Each sample was then loaded onto the 
gel lanes with a standard (Bio-Rad prestained protein marker) and 1x non-reducing 
sample buffer solutions in any of the lanes that were empty. The gels were then loaded 
 43 
into a Bio-Rad (Hercules, CA) electrophoresis apparatus filled with 1X electrode buffer 
(diluted with ddH2O from 10x buffer: 25 mM Tris, 192 mM glycine, 0.1% SDS) that was 
submersed in a cooler filled with ice. The apparatus was ran at 90V for 90 minutes. After 
the gels were removed from the apparatus, they were washed with 100 mL of 2.5% 
Triton X-100 for 30 minutes for 30 minutes in order to remove the SDS. The gels were 
moved to a closed container with development buffer (50 mM Tris-HCl, pH 7.5, 200 mM 
NaCl, 0.2% Brij-35, 5 mM CaCl2) and incubated on a shaker overnight at 37˚C. The next 
day, the gels were stained with 40% methanol, 50% water, 10% glacial acetic acid, and 
0.5% Coomassie Brilliant Blue R-250 (#161-0400, Bio-Rad) for 45 minutes. The gels 
were destained with 40% methanol, 10% acetic acid, and 50% water for 2 hours (until the 
clear bands formed on the blue background and standards were visible), changing the 
solution every 30 minutes. The gels were then photographed using the Bio-Rad digital 
camera under the “light bands” setting. 
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CHAPTER THREE 
RESULTS 
3.1.   Experimental Groups 
 The experimental groups for analyzation of the cellular interactions were 
organized into the interactions shown in Figure 3.1.  The goal of this organization was to 
compare interactions in media with a high glucose level vs normal media. 
 
Figure 3.1. Schematic of Experimental Groups 
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3.2   Alkaline Phosphatase Expression 
Alkaline phosphatase is involved in cleaving a calcification inhibitor during 
vascular calcification, and was one of the calcification biomarkers that was a focus of this 
research. Immunostaining works through the binding of primary and secondary 
antibodies. Antibodies are molecules produced by the body’s immune system in order to 
recognize foreign proteins to be removed from the body. An antigen is the molecule 
which is recognized and tagged by the antibody. The part of an antigen that is recognized 
is called the epitope. Once the antibody is allowed to attach to the epitope on the antigen, 
the secondary that is conjugated with a fluorescent molecule binds to the primary 
antibody to create the positive signal in images. After the proteins are tagged for alkaline 
phosphatase, immunofluorescent imaging was performed at a magnification of 20X to 
obtain the following pictures.  
The first set is the vascular smooth muscle cells that were co-cultured with the 
other cell types, as indicated to the left of the images, and the second is the adventitial 
fibroblasts.  The red color signifies a positive stain for the protein, with the blue DAPI 
stain showing where the cell nuclei are.  All of the groups stained positive for alkaline 
phosphatase presence. This could be because alkaline phosphatase is involved in cleaving 
phosphate groups, which is a common cellular process in all cells. If the cells were in 
culture for a month with high glucose levels, it has been shown that there would be a 
higher presence more in the diabetic group.  We did this in order to see if there were early 
modifications, which did not seem apparent based on the images. 
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Figure 3.2. Expression of alkaline phosphatase in vascular smooth muscle cells. The top 
four images are SMCs cultured on the Transwell membrane interacting with the other 
cell type signified to the left of the images cultured on the bottom of the well. The 
bottom four images are SMCs cultured on the bottom of the well plate with the other 
cell types signified to the left of the images cultured on Transwell membrane. 
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Figure 3.3. Alkaline phosphatase expression in adventitial fibroblasts. The top four 
images are FBs cultured on the Transwell membrane interacting with the other cell 
type signified to the left of the images cultured on the bottom of the well. The bottom 
four images are FBs cultured on the bottom of the well plate with the other cell types 
signified to the left of the images cultured on Transwell membrane. 
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A Western Blot was done in order to quantify the amount of alkaline phosphatase 
and osteocalcin that were present in the cells. Instead of using a protein in the wells with 
a known concentration, we normalized each solution to 20 ug/mL, so each well had the 
same amount of protein.  The osteocalcin was not visible from this assay, but the pictures 
of the blots and corresponding densitometric analyses of alkaline phosphatase (molecular 
weight about 57-66kDa) for each sample are shown in Figure 3.4, Figure 3.5, Figure 
3.6, and Figure 3.7. Although there didn’t seem to be apparent differences from the 
immunofluorescence images, we can observe some quantifiable differences from this 
technique.   
In Figure 3.4, we can see that the fibroblasts on the well surface produced more 
alkaline phosphatase than any other cell type—the highest level of alkaline phosphatase 
being produced by the fibroblasts cultured with smooth muscle cells in diabetic media.  
There did not seem to be any significant differences in the alkaline phosphatase 
production of the other groups cultured in diabetic media on the well plate surface 
(Figure 3.4).  When comparing these results to the relative alkaline phosphatase levels in 
Figure 3.5, we can see that when cultured in nondiabetic media, the fibroblasts 
cocultured with endothelial cells did not have as much alkaline phosphatase activity as 
when cultured in diabetic media.  The fibroblasts that were cultured with smooth muscle 
cells were still the group which produced the most alkaline phosphatase, but this alkaline 
phosphatase production from this interaction seems to be less dependent on glucose 
levels. 
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Figure 3.6 indicates that the group with the most alkaline phosphatase on the 
Transwell membrane in diabetic conditions was the smooth muscle cells cultured with 
endothelial cells. This data supports publications that indicate endothelial cells produce 
cytokines to induce the transdifferentiation of smooth muscle cells in calcification as well 
as the thought that smooth muscle cells are a key cell in transdifferentiation to osteoblasts 
in high glucose levels [28].  An also notable comparison is that the smooth muscle cells 
that were cultured with fibroblasts and fibroblasts cultured with endothelial cells showed 
higher levels of alkaline phosphatase compared to the other groups. A surprisingly low 
alkaline phosphatase level is seen in the fibroblasts that were cultured with smooth 
muscle cells. This was one of the two groups that displayed positive expression of 
osteocalcin in the images shown in the next section. 
Blot 4, which is presented in Figure 3.7 had lower intensity volumes overall, so 
the image may not be as reliable.  This analysis indicated that in the normal media, the 
group with the highest expression of alkaline phosphatase was the fibroblasts cultured 
with smooth muscle cells. This is consistent with the results from Figure 3.5, where they 
were cultured in nondiabetic media on the well plate surface.  Also consistent with the 
results from the well plate surface data, is that the fibroblasts cultured with endothelial 
cells have lower levels of alkaline phosphatase comparted to the other groups than they 
did in the diabetic cultured membrane surfaces.  
These quantitative analyses made comparisons possible that were not evident in 
the images. 
 
 50 
 
Alkaline Phosphatase Blot 1 – Diabetic Media, Well Surfaces 
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Figure 3.4. Diabetic Media, Well Surface Groups for Western Blot. Western blot membrane and 
corresponding densitometric analysis for the presence of alkaline phosphatase for cells cultured in 
diabetic media on the well plate surface. The first acronym in each group represents the cell 
cultured on the membrane surface above the analyzed cell type and the second acronym 
represents the cell type on the surface of the well plate. 
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Alkaline Phosphatase Blot 2 – Control Media, Well Surfaces 
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Figure 3.5. Nondiabetic Media, Well Surface Groups for Western Blot. Western blot membrane 
and corresponding densitometric analysis for the presence of alkaline phosphatase for cells 
cultured in nondiabetic media on the well plate surface. The first acronym in each group 
represents the cell cultured on the membrane surface above the analyzed cell type and the second 
acronym represents the cell type on the surface of the well plate. 
75 kDa 
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Alkaline Phosphatase Blot 3- Diabetic Media, Membrane Surface 
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Figure 3.6. Diabetic Media, Membrane Surface Groups for Western Blot. Western blot 
membrane and corresponding densitometric analysis for the presence of alkaline phosphatase for 
cells cultured in diabetic media on the Transwell membrane surface. The first acronym in each 
group represents the analyzed cell type cultured on the membrane surface and the second 
acronym represents the interacting cell type on the surface of the well plate below the analyzed 
cell type. 
75 kDa 
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Alkaline Phosphatase Blot 4 - Control Media, Membrane Surface 
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Figure 3.7. Nondiabetic Media, Membrane Surface Groups for Western Blot. Western blot 
membrane and corresponding densitometric analysis for the presence of alkaline phosphatase for 
cells cultured in nondiabetic media on the Transwell membrane surface. The first acronym in 
each group represents the analyzed cell type cultured on the membrane surface and the second 
acronym represents the interacting cell type on the surface of the well plate below the analyzed 
cell type. 
 
75 kDa 
 54 
3.3.   Osteocalcin 
The next images are the only groups that stained positive for both alkaline 
phosphatase in red and osteocalcin in green.  The calcification biomarker, osteocalcin, 
was only seen in two groups. Both groups were cultured in diabetic media, the positive 
cell type cultured on the membrane, and caused by an interaction between smooth muscle 
cells and fibroblasts.  The first image is the HCASMCs cultured on the membrane of the 
Transwell inserts with the fibroblasts on the bottom of the well plate below them cultured 
in diabetic media.  
 
Figure 3.8. HCASMC in conditions expressing osteocalcin and alkaline phosphate.  This is an 
image taken of the vascular smooth muscle cells cultured on the membrane of the Transwell 
inserts with the fibroblasts on the bottom of the well plate below them cultured in diabetic media 
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The other group that had positive expression of both biomarkers was also in 
diabetic media and with the interaction of vascular smooth muscle cells and fibroblasts, 
but in this case, the fibroblasts were the cells with osteocalcin expression. This suggests 
that the interaction of these two cell types under hyperglycemic conditions in the body 
may contribute to vascular calcification in diabetes. 
 
Figure 3.9. HAoAFB in conditions expressing osteocalcin and alkaline phosphate.  This is an 
image taken of the adventitial fibroblasts cultured on the membrane of the Transwell inserts with 
the smooth muscle cells on the bottom of the well plate below them cultured in diabetic media. 
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3.4.   Caspase-3 
All of the caspase-3 immunofluoresent images shown were taken at a 
magnification of 20X and are representative of each group. The groups of images shown 
below are the immunofluorescent stain for caspase-3, the enzyme involved in apoptosis 
execution. We chose to focus on the caspase-3 enzyme because it is a main effector in 
apoptosis of vascular cell and is one of the last caspases in the cascade.  The first set of 
images are of the vascular smooth muscle cells that were co-cultured with the other cell 
types and the second is the adventitial fibroblasts. Again, the red color signifies a positive 
stain for the protein, with the blue DAPI stain showing where the cell nuclei are.  
All of the cells, regardless of culturing conditions, seemed to be undergoing 
apoptosis. We had not performed this culturing technique before, so it needs to be 
optimized in order to avoid apoptosis. One theory of why apoptosis was initiated is that 
the cells were not able to get enough oxygen. This would activate the intrinsic pathway of 
apoptosis through intracellular signaling. The cells would probably also benefit from 
fluid flow across the surface since that is seen in the physiological conditions, so putting 
the 6-well plates containing the Transwell membrane on a shaker with slight circular 
movement while they incubate may help prevent apoptosis if this study were to be 
repeated. When the media is rotating around the well and membrane, the distance from 
the cells to the oxygen source (air) would be shorter on the opposite side that the shaker 
is tilting towards. 
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Figure 3.10. Vascular smooth muscle cells undergoing apoptosis. The top four images 
are SMCs cultured on the Transwell membrane interacting with the other cell type 
signified to the left of the images cultured on the bottom of the well. The bottom four 
images are SMCs cultured on the bottom of the well plate with the other cell types 
signified to the left of the images cultured on Transwell membrane. 
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Figure 3.11. Adventitial fibroblasts undergoing apoptosis. The top four images are 
FBs cultured on the Transwell membrane interacting with the other cell type signified 
to the left of the images cultured on the bottom of the well. The bottom four images 
are FBs cultured on the bottom of the well plate with the other cell types signified to 
the left of the images cultured on Transwell membrane. 
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3.5.          Calcium Analysis 
The stain that was performed for qualitative analysis of calcium deposits was 
Alizarin Red Solution. It forms a complex with calcium through chelation and produces 
red refraction indication the presence of calcium.  This stained positives in all groups as 
well because anything stained signifies a calcium in the cell, not just calcium phosphate 
crystals in calcification. We expected to see cell clusters and calcium accumulation in the 
groups, but did not see this with 2 weeks of culture. 
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Figure 3.12. Calcium deposits in vascular smooth muscle cells. The samples were 
imaged using light microscopy. The four images are SMCs cultured on the bottom 
of the well plate with the other cell types signified to the left of the images cultured 
on Transwell membrane. Red signifies the presence of calcium deposits. 
 60 
    Control    Diabetic  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
3.6.          MMP Detection 
 Gelatin zymography was performed in order to analyze the matrix 
metalloprotease content of the media from each group.  There were no MMPs seen in any 
of the groups (Figure 3.14), but this is not indicative that there may not be any in the 
media, it is most likely due to an error when executing the procedure. In order to 
analyze protein content before the gelatin zymography and Western Blots, BCA assay 
was performed, then, a standard curves were generated that displayed the total protein 
FB on 
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Figure 3.13. Calcium deposits in adventitial fibroblasts. The cells were imaged 
using light microscopy. The four images are FBs cultured on the bottom of the 
well plate with the other cell types signified to the left of the images cultured on 
Transwell membrane. Red signifies the presence of calcium deposits. 
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concentration that corresponded to each absorbance. The data acquired experimentally 
for the media samples and surface extracted samples was then normalized with the use of 
the BCA standard curves (Figure 3.15 and Figure 3.16). 
 
Figure 3.14. Zymography gel with standard on left edge 
 
 
Figure 3.15. BCA standard curve for media samples 
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Figure 3.16. BCA standard curve for surface extracted samples
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CHAPTER FOUR 
DISCUSSION & CONCLUSION 
4.1.          Discussion  
Our approach to understanding the cellular interactions underlying vascular 
calcification in diabetic patients was effective in some aspects, but could also be 
improved. We co-cultured each combination of vascular smooth muscle cells, fibroblasts, 
and endothelial cells on Transwell membrane surfaces and bottom of well plate surfaces 
under high glucose levels and compared them to the same groups in nondiabetic 
conditions. To observe the interactions, we performed immunofluoresent and Alizarin 
Red Solution staining, Western blots, and gelatin zymography.  
The rationale behind the staining was to see if we could observe the presence of 
calcification markers, from imaging. The caspase-3 staining shows if the cells undergo 
apoptosis, which they did, but could be a marker of calcification if the apoptosis is due to 
high levels of calcium. There was no observed differences in the co-culture groups so the 
apoptosis was probably due to a lack of nutrients.  The Alizarin Red Solution stain was 
performed to analyze the presence of calcium. High levels of cytoplasmic calcium can 
also cause calcification, and is therefore a biomarker of calcification.  We expected to see 
the cells in clusters and calcium accumulations, but it was possibly too early to see this 
modification.   
Osteocalcin is a bone protein and signifies transdifferentiation to an osteogenic 
phenotype.  Based on the immunofluoresent images (Figure 3.8, Figure 3.9), vascular 
smooth muscle cells and fibroblasts transdifferentiate to an osteogenic phenotype when 
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exposed to high glucose levels and specific media components secreted from the other 
cell type.  It has been shown that fibroblasts express bone-regulating proteins when 
exposed to deteriorated matrix environments that would be present in calcification [25]. 
They may do this, first, through transformation to myofibroblasts under stress and 
eventually osteoblasts [47]. This means that they play a role in calcification, but it has not 
been shown that they can express these bone proteins under high glucose levels—a 
missing link may have been the smooth muscle cells are activating them through a 
paracrine mechanism in the presence of elevated glucose levels.  There is in vivo 
evidence to support that alterations in signaling molecules can affect smooth muscle cell 
function and other cell types through a paracrine mechanism [16]. 
Alkaline phosphatase cleaves calcification inhibitors and is, therefore, also a 
biomarker of calcification. We did not see any differences based on the images, so looked 
to quantitative analysis for more information.  To further analyze the calcification 
biomarker expression shown in the images, we did a Western Blot. The western blot did 
not show up for osteocalcin, this may have been to the “gel sandwich” not being 
completely submerged in solution during assembly, causing bubbles during the transfer 
of protein expression to the membrane. The alkaline phosphatase data did show up and 
was able to be used in order to compare activity between the co-culture groups. 
 In nondiabetic media, the fibroblasts co-cultured with endothelial cells did not 
have as much alkaline phosphatase activity compared to the other groups as when 
cultured in diabetic media (Figure 3.4, Figure 3.5, Figure 3.6, and Figure 3.7). This 
data is suggestive that high glucose levels may induce endothelial cells to release 
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cytokines that initiate an osteogenic phenotype in fibroblasts. Co-cultures of fibroblasts 
and endothelial cells have been studied before in order to understand angiogenesis 
interactions, with seeing that they do affect each other [48].  Other in vivo studies have 
shown that active adventitial fibroblasts, myofibroblasts, contribute to the formation of a 
neointima following vascular injury [16] and can undergo proliferation, dramatic 
phenotype changes, and migration [16].  In multiple setups of the different co-cultures 
(Figure 3.4, Figure 3.5, Figure 3.7) fibroblasts that were cultured with smooth muscle 
cells were still the group which produced the most alkaline phosphatase, so alkaline 
phosphatase produced from this interaction seems to be less dependent on glucose levels 
and may be due to another paracrine mechanism where smooth muscle cells since 
environmental signals (or lack of) and initiate the transdifferentiation of fibroblasts. This 
hypothesis is supported by the Western Blot shown in Figure 3.6, where there are 
surprisingly low alkaline phosphatase levels under diabetic conditions. The images 
showed that this group, specifically when cultured on the membrane, had positive 
expression of osteocalcin. That means that the fibroblast had changed to an osteogenic 
phenotype, at least to some degree, even though the alkaline phosphatase levels weren’t 
as high.    
When cultured in diabetic conditions and on the Transwell membrane surface (the 
most reliable surface for receiving signals from the cell below) the group with the most 
alkaline phosphatase was the smooth muscle cells cultured with endothelial cells. This 
data supports publications that indicate endothelial cells produce cytokines to induce the 
transdifferentiation of smooth muscle cells in calcification as well as the thought that 
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smooth muscle cells are a key cell in transdifferentiation to osteoblasts in high glucose 
levels. Endothelial cells most likely play a key role in any pathology of blood vessels 
because they are in direct contact with the blood and the pressures, cytokines, hormones, 
and proteins that accompany it.  This is why this study should be performed again with 
different media for co-culturing.  If this study is conducted again, it would also be 
beneficial to run the same cell co-cultures on the same Western Blots in order to get a 
more accurate comparison. This was broken up based on the media conditions, which is 
not beneficial due to the comparison only being a relative amount of proteins within each 
blot. The endothelial cells were apoptotic before they were analyzed, so we could not 
retrieve any images or quantitative analysis from these important cells.  
This study was conducted in order to see early modifications of the cells, but after 
they are transdifferentiated into osteoblasts they initiate the calcification of extracellular 
matrix components, such as elastin and collagen. After there is a better understanding of 
the early modifications, it is important to understand the role of the cellular-extracellular 
matrix interactions as well. 
 
4.2.          Conclusions  
This research highlights the importance of studying cellular interactions within 
the blood vessels in order to further define the mechanism of calcification in diabetic 
patients. This approach was effective because it did not include ECM components, which 
also play a large role in calcification, in order to focus solely on the interactions of the 
cells in high glucose conditions. These results show novel information about 
 67 
modifications of fibroblasts and smooth muscle cells when co-cultured in diabetic 
conditions. Differences between the alkaline phosphate levels of each co-culture group 
were not apparent based on the immunofluorescence qualitative analysis but, through the 
use of Western Blot analyses, we were able to compare the intensity volumes between the 
groups.  
Based on the immunofluorescence images (Figure 3.8, Figure 3.9), vascular 
smooth muscle cells and fibroblasts transdifferentiate to an osteogenic phenotype when 
exposed to high glucose levels and specific media components secreted from the other 
cell type.  In nondiabetic media, the fibroblasts cultured with endothelial cells did not 
have as much alkaline phosphatase activity compared to the other groups as when 
cultured in diabetic media (Figure 3.4, Figure 3.5, Figure 3.6, and Figure 3.7). 
Fibroblasts that were cultured with vascular smooth muscle cells produced the most 
alkaline phosphatase, regardless of the level of glucose in culture media, but only 
secreted osteocalcin when exposed to high glucose levels. 
In diabetic conditions and on the Transwell membrane (the most reliable surface 
for receiving signals from the cells below) the group with the most alkaline phosphatase 
was the smooth muscle cells cultured with endothelial cells. This data supports 
publications that indicate endothelial cells produce cytokines to induce the 
transdifferentiation of smooth muscle cells in calcification as well as the thought that 
smooth muscle cells are a key vascular cell in transdifferentiation to osteoblasts when 
exposed to high glucose levels.  
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4.3.          Future Directions  
 For future studies, I would first recommend redoing this 2D co-culture study with 
a different type of medium (such as phenol red-free DMEM supplemented with 2% FBS 
and penicillin/streptomycin).  Hopefully, this would prevent apoptosis in the endothelial 
cells. During the analyzation of results, it would also be beneficial to look at the gene 
expression in the cellular interactions.  In order to further understand the specific 
mechanism behind these interactions we could inhibit specific cytokines and growth 
factors on one cell type and co-culture the cells again to see if there are still biomarkers 
of calcification. If there are not when a certain cytokine is blocked, that means that 
cytokine is responsible in the interaction between the cells in diabetic conditions.   
 A 3D cell culture should also be performed with spheroids in order to analyze any 
differences that the cultures have from the 2D cultures. After the spheroid study, it would 
be necessary to seed all three cell types onto a decellularized scaffold in order to analyze 
their interactions with each other and the ECM components and fluid flow. The 
importance of fluid flow on the vascular cells is highlighted in the introduction, but this 
study did not include that data.  It is not a complete vascular calcification model without 
the ECM components and fluid dynamics. 
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